Literature DB >> 7790396

Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide.

J Delbé1, F Vacherot, K Laaroubi, D Barritault, J Courty.   

Abstract

HARP (heparin affin regulatory peptide) is an 18 kDa heparin binding protein, also known as HB-GAM or pleiotrophin (PTN) which has been primarily isolated from brain and uterus, and displays neurite outgrowth, angiogenic and mitogenic activities. Previously, we have expressed the human cDNA encoding human HARP in NIH 3T3 cells. Purified recombinant HARP displayed mitogenic activity for endothelial cells. Its NH2-terminal sequence indicates that the HARP molecule possesses a three amino acid extension from the signal peptide more than the NH2-terminal described. For HB-GAM or PTN, these three amino acids may be essential for the stability and the mitogenic activity of this growth factor. In an attempt to further study the mode of action of this growth factor, we have investigated the mitogenic effect of HARP on various cell types. In contrast to FGF-2, HARP failed to induce stimulation of DNA synthesis on a CCL39 cell line. However, we found that in quiescent bovine epithelial lens (BEL) cells, the stimulation of DNA synthesis induced by HARP is dose-dependent (EC50: 2.5 ng/ml) and maximal stimulation is as potent as that induced by FGF-2 (EC50: 25 pg/ml). Interestingly, when BEL cells were allowed to quiesce in the presence of serum, the stimulation induced by HARP is considerably less potent. In this highly responsive cell system, heparin could potentiate the mitogenic activity of HARP at very low doses (0.1-1 microgram/ml) and inhibit this activity at concentrations of 10 micrograms/ml. In contrast to its protective effect on FGF-1 and -2, heparin was unable to preserve HARP from tryptic and chymotryptic degradations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790396     DOI: 10.1002/jcp.1041640107

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Pleiotrophin regulates serine phosphorylation and the cellular distribution of beta-adducin through activation of protein kinase C.

Authors:  Harold Pariser; Gonzalo Herradon; Laura Ezquerra; Pablo Perez-Pinera; Thomas F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

2.  Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta.

Authors:  K Meng; A Rodriguez-Peña; T Dimitrov; W Chen; M Yamin; M Noda; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Identification of heparin-binding sites in proteins by selective labeling.

Authors:  Alessandro Ori; Paul Free; José Courty; Mark C Wilkinson; David G Fernig
Journal:  Mol Cell Proteomics       Date:  2009-06-30       Impact factor: 5.911

4.  Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.

Authors:  Weiwen Wang; Michelle E LeBlanc; Xiuping Chen; Ping Chen; Yanli Ji; Megan Brewer; Hong Tian; Samantha R Spring; Keith A Webster; Wei Li
Journal:  Angiogenesis       Date:  2017-04-26       Impact factor: 9.596

5.  Upregulation of heparin-affin regulatory peptide by androgen.

Authors:  F Vacherot; K Laaroubi; D Caruelle; J Delbe; D Barritault; J P Caruelle; J Courty
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-10       Impact factor: 2.416

6.  Loss of receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ) promotes prostate cancer metastasis.

Authors:  Zoi Diamantopoulou; Paraskevi Kitsou; Suzanne Menashi; Jose Courty; Panagiotis Katsoris
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

7.  Pleiotrophin/heparin-binding growth-associated molecule as a mitogen of rat hepatocytes and its role in regeneration and development of liver.

Authors:  Kinji Asahina; Hajime Sato; Chihiro Yamasaki; Miho Kataoka; Miho Shiokawa; Shigeru Katayama; Chise Tateno; Katsutoshi Yoshizato
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.